Sulforaphane
- Generic Name
- Sulforaphane
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C6H11NOS2
- CAS Number
- 142825-10-3
- Unique Ingredient Identifier
- GA49J4310U
- Background
Sulforaphane is under investigation for the treatment of Autism Spectrum Disorder. It is a naturally occurring isothiocyanate found in high concentration in a variety of broccoli.
- Associated Conditions
- -
- Associated Therapies
- -
Safety, Feasibility, and Tolerability of Sulforaphane in Children With Chronic Kidney Disease
- First Posted Date
- 2022-12-16
- Last Posted Date
- 2023-08-09
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 12
- Registration Number
- NCT05653492
- Locations
- πΊπΈ
University of Rochester Medical Center, Rochester, New York, United States
Prevention of Age-associated Cardiac and Vascular Dysfunction Using Avmacol ES
- Conditions
- Diastolic DysfunctionSystolic DysfunctionDiastolic Heart Failure
- Interventions
- First Posted Date
- 2022-06-07
- Last Posted Date
- 2024-11-06
- Lead Sponsor
- Texas Tech University Health Sciences Center
- Target Recruit Count
- 200
- Registration Number
- NCT05408559
- Locations
- πΊπΈ
Texas Tech University Health Sciences Center (TTUHSC), Lubbock, Texas, United States
Sulforaphane Use to Effect Inflammatory and Metabolic Changes in Virally Suppressed HIV Patients
- First Posted Date
- 2022-02-04
- Last Posted Date
- 2022-02-07
- Lead Sponsor
- Sunshine Specialty Health Care
- Target Recruit Count
- 20
- Registration Number
- NCT05224492
Study of Sulphoraphane in Chronic Kidney Disease
- Conditions
- Chronic Kidney Disease stage3Chronic Kidney Disease stage4
- Interventions
- First Posted Date
- 2021-12-10
- Last Posted Date
- 2024-08-12
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 18
- Registration Number
- NCT05153174
- Locations
- πΊπΈ
University of Rochester Medical Center, Rochester, New York, United States
A 6-month Study to Evaluate Sulforaphane Effects in PD Patients
- First Posted Date
- 2021-10-19
- Last Posted Date
- 2023-07-06
- Lead Sponsor
- Central South University
- Target Recruit Count
- 100
- Registration Number
- NCT05084365
- Locations
- π¨π³
Mental Health Institute of Second Xiangya Hospital,CSU, Changsha, Hunan, China
A 6-month Study to Evaluate Sulforaphane Effects in Schizophrenia Patients
- First Posted Date
- 2020-08-21
- Last Posted Date
- 2023-04-26
- Lead Sponsor
- Central South University
- Target Recruit Count
- 125
- Registration Number
- NCT04521868
- Locations
- π¨π³
Second Xiangya Hospital, Changsha, Hunan, China
Effects of Sulforaphane on Cognitive Function in Patients With Frontal Brain Damage
- First Posted Date
- 2020-02-05
- Last Posted Date
- 2020-05-19
- Lead Sponsor
- Xiangya Hospital of Central South University
- Target Recruit Count
- 90
- Registration Number
- NCT04252261
A 12-weeks Study to Evaluate Sulforaphane in the Treatment of Depression
- Conditions
- Depressive Disorder
- Interventions
- First Posted Date
- 2020-01-29
- Last Posted Date
- 2020-08-20
- Lead Sponsor
- Central South University
- Target Recruit Count
- 90
- Registration Number
- NCT04246905
- Locations
- π¨π³
Mental Health Institute of Second Xiangya Hospital,CSU, Changsha, Hunan, China
Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction
- Conditions
- Anthracycline Related Cardiotoxicity in Breast Cancer
- Interventions
- Drug: Placebo Oral TabletDrug: sulforaphane
- First Posted Date
- 2019-05-02
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Texas Tech University Health Sciences Center
- Target Recruit Count
- 70
- Registration Number
- NCT03934905
- Locations
- πΊπΈ
Texas Tech University Health Sciences Center, Lubbock, Texas, United States
Effect of Topical Sulforaphane on Skin Fragility Seen in Skin Aging and With Ultraviolet Exposure
- Conditions
- Aging
- Interventions
- First Posted Date
- 2017-04-24
- Last Posted Date
- 2023-06-29
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 9
- Registration Number
- NCT03126539
- Locations
- πΊπΈ
Cutaneous Translational Research Program, Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.